| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.45 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |